Drug Type Unknown |
Synonyms ML105 |
Target |
Mechanism CLK4 inhibitors(CDC like kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization MapLight Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization MapLight Therapeutics, Inc.Startup |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder | Discovery | US | MapLight Therapeutics, Inc.Startup | 27 Apr 2023 |